limestone has been researched along with Disease Exacerbation in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (40.00) | 29.6817 |
| 2010's | 6 (40.00) | 24.3611 |
| 2020's | 3 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agarwal, K; Cherian, KE; Kapoor, N; Paul, TV | 1 |
| Culty, T; Demiselle, J; Meria, P; Sigogne, M | 1 |
| Fujii, H; Goto, S; Kono, K; Nishi, S; Watanabe, K | 1 |
| Furuya, R; Hidaka, S; Ishioka, K; Iwagami, M; Kobayashi, S; Maesato, K; Mochida, Y; Moriya, H; Ohtake, T; Oka, M; Tsutsumi, D | 1 |
| Wada, K; Wada, Y | 1 |
| Bellasi, A; Di Iorio, B; Pota, A; Russo, D; Russo, L | 1 |
| Kitazono, T; Noguchi, H; Ooboshi, H; Tatsumoto, N; Tokumoto, M; Tsuruya, K; Yamada, S | 1 |
| Drożdż, D; Drożdż, T; Kwinta, P; Miklaszewska, M; Pietrzyk, JA; Sztefko, K; Zachwieja, K; Łatka, M | 1 |
| Hori, K; Izumi, M; Kasumoto, H; Kitamura, R; Miyamoto, T; Morita, S; Nakanishi, T; Nishian, Y; Oue, M; Yamamoto, S | 1 |
| Fujimori, A; Fukushima, S; Itoh, H; Mizukami, K; Nara, H; Okada, M; Sanagi, M; Takakura, K; Terai, K | 1 |
| Inaguma, D; Tatematsu, M | 1 |
| Kerr, PG; Lau, KK; Polkinghorne, KR; Toussaint, ND | 1 |
| Akiba, T; Kabaya, T; Kawashima, A; Nihei, H; Nitta, K; Uchida, K; Yumura, W | 1 |
| Davies, MR; Hruska, KA; Lund, RJ; Mathew, S | 1 |
| Akiba, T; Kabaya, T; Matsugami, K; Mimuro, T; Nitta, K; Otsubo, S; Takei, T; Uchida, K | 1 |
1 review(s) available for limestone and Disease Exacerbation
| Article | Year |
|---|---|
[Chronic kidney disease (CKD) and bone. Chronic kidney disease--mineral and bone disorder in predialysis patients].
Topics: Bone Diseases, Metabolic; Calcium Carbonate; Chronic Disease; Dialysis; Disease Progression; Humans; Hyperparathyroidism, Secondary; Hypocalcemia; Kidney Diseases; Phosphorus; Vitamin D; Vitamin D Deficiency | 2009 |
5 trial(s) available for limestone and Disease Exacerbation
| Article | Year |
|---|---|
Lanthanum carbonate delays progression of coronary artery calcification compared with calcium-based phosphate binders in patients on hemodialysis: a pilot study.
Topics: Aged; Calcinosis; Calcium; Calcium Carbonate; Chelating Agents; Coronary Artery Disease; Disease Progression; Female; Follow-Up Studies; Humans; Lanthanum; Male; Middle Aged; Parathyroid Hormone; Phosphates; Pilot Projects; Prospective Studies; Renal Dialysis; Time Factors; Treatment Outcome | 2013 |
Evaluation of aortic calcification with lanthanum carbonate vs. calcium-based phosphate binders in maintenance hemodialysis patients with type 2 diabetes mellitus: an open-label randomized controlled trial.
Topics: Aged; Aortic Diseases; Calcinosis; Calcium Carbonate; Chelating Agents; Diabetes Mellitus, Type 2; Disease Progression; Female; Humans; Lanthanum; Male; Middle Aged; Phosphates; Renal Dialysis; Renal Insufficiency, Chronic; Tomography, X-Ray Computed | 2014 |
Effects of phosphorus-restricted diet and phosphate-binding therapy on outcomes in patients with chronic kidney disease.
Topics: Aged; Calcium Carbonate; Cause of Death; Chelating Agents; Coronary Vessels; Disease Progression; Female; Follow-Up Studies; Humans; Male; Middle Aged; Phosphorus; Phosphorus, Dietary; Renal Dialysis; Renal Insufficiency, Chronic; Sevelamer; Vascular Calcification | 2015 |
Attenuation of aortic calcification with lanthanum carbonate versus calcium-based phosphate binders in haemodialysis: A pilot randomized controlled trial.
Topics: Adult; Aged; Aortic Diseases; Aortography; Biomarkers; Bone Density; Calcinosis; Calcium; Calcium Carbonate; Chelating Agents; Disease Progression; Female; Humans; Kidney Diseases; Lanthanum; Linear Models; Lumbar Vertebrae; Male; Middle Aged; Parathyroid Hormone; Phosphates; Pilot Projects; Renal Dialysis; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Victoria | 2011 |
Effects of sevelamer on the progression of vascular calcification in patients on chronic haemodialysis.
Topics: Aged; Analysis of Variance; Aorta, Abdominal; Aortic Diseases; Biomarkers; C-Reactive Protein; Calcinosis; Calcium; Calcium Carbonate; Chelating Agents; Disease Progression; Female; Humans; Kidney Failure, Chronic; Lipids; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Polyamines; Renal Dialysis; Sevelamer; Severity of Illness Index; Statistics, Nonparametric; Tomography, X-Ray Computed | 2008 |
9 other study(ies) available for limestone and Disease Exacerbation
| Article | Year |
|---|---|
Chalky adrenals: a sequelae of antiphospholipid syndrome.
Topics: Adrenal Glands; Antiphospholipid Syndrome; Calcium Carbonate; Disease Progression; Humans; Methamphetamine | 2022 |
Encrusted pyelitis in a kidney allograft.
Topics: Allografts; Anti-Bacterial Agents; Calcinosis; Calcium Carbonate; Citrates; Corynebacterium; Disease Progression; Drug Combinations; Female; Humans; Kidney Pelvis; Kidney Transplantation; Magnesium Oxide; Middle Aged; Nephrostomy, Percutaneous; Polycystic Kidney, Autosomal Dominant; Pyelitis; Tomography, X-Ray Computed; Ureter; Vancomycin | 2020 |
Comparison of the effects of lanthanum carbonate and calcium carbonate on the progression of cardiac valvular calcification after initiation of hemodialysis.
Topics: Aged; Aged, 80 and over; Biomarkers; Calcinosis; Calcium Carbonate; Chelating Agents; Disease Progression; Female; Heart Valve Diseases; Humans; Kidney Diseases; Lanthanum; Male; Middle Aged; Phosphorus; Randomized Controlled Trials as Topic; Renal Dialysis; Risk Factors; Time Factors; Treatment Outcome | 2020 |
Phosphate binders prevent phosphate-induced cellular senescence of vascular smooth muscle cells and vascular calcification in a modified, adenine-based uremic rat model.
Topics: Adenine; Animal Feed; Animals; Calcinosis; Calcium Carbonate; Cellular Senescence; Disease Models, Animal; Disease Progression; Fibrosis; Immunohistochemistry; Inflammation; Kidney; Kidney Failure, Chronic; Lanthanum; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Oxidative Stress; Phosphates; Rats; Rats, Sprague-Dawley; Renal Insufficiency, Chronic; Signal Transduction; Uremia; Vascular Calcification | 2015 |
[Do we successfully treat anemia and calcium-phosphate disorders in children with chronic kidney disease at the beginning of the twenty-first century?].
Topics: Adolescent; Anemia; Calcium Carbonate; Child; Disease Progression; Erythropoietin; Female; Humans; Hydroxycholecalciferols; Hyperphosphatemia; Hypocalcemia; Male; Parathyroid Hormone; Renal Insufficiency, Chronic; Treatment Outcome | 2015 |
Switching from calcium carbonate to sevelamer hydrochloride has suppressive effects on the progression of aortic calcification in hemodialysis patients: assessment using plain chest X-ray films.
Topics: Aged; Antacids; Aortic Diseases; Calcinosis; Calcium Carbonate; Chelating Agents; Disease Progression; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Polyamines; Radiography, Thoracic; Renal Dialysis; Retrospective Studies; Sevelamer | 2008 |
Vascular calcification and secondary hyperparathyroidism of severe chronic kidney disease and its relation to serum phosphate and calcium levels.
Topics: Adenine; Animals; Aortic Diseases; Biomarkers; Blood Urea Nitrogen; Calcinosis; Calcium; Calcium Carbonate; Chelating Agents; Cholecalciferol; Chronic Disease; Creatinine; Disease Models, Animal; Disease Progression; Hyperparathyroidism, Secondary; Hyperphosphatemia; Hypocalcemia; Kidney Diseases; Male; Parathyroid Hormone; Phosphates; Polyamines; Rats; Rats, Wistar; Sevelamer; Severity of Illness Index; Time Factors | 2009 |
The progression of vascular calcification and serum osteoprotegerin levels in patients on long-term hemodialysis.
Topics: Aortic Diseases; Arteriosclerosis; C-Reactive Protein; Calcinosis; Calcium; Calcium Carbonate; Disease Progression; Female; Glycoproteins; Humans; Kidney Failure, Chronic; Lipids; Longitudinal Studies; Male; Middle Aged; Osteoprotegerin; Parathyroid Hormone; Phosphorus; Prospective Studies; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Renal Dialysis; Risk Factors | 2003 |
Connections between vascular calcification and progression of chronic kidney disease: therapeutic alternatives.
Topics: Animals; Aorta, Thoracic; Bone Diseases; Bone Morphogenetic Protein 7; Bone Morphogenetic Proteins; Calcinosis; Calcium; Calcium Carbonate; Chronic Disease; Chronic Kidney Disease-Mineral and Bone Disorder; Dietary Fats; Disease Progression; Female; Hyperparathyroidism; Kidney Diseases; Male; Mice; Mice, Inbred C57BL; Osteoblasts; Osteogenesis; Phosphates; Renal Insufficiency, Chronic; Transforming Growth Factor beta | 2005 |